Intellectual property tokenisation is one of the most institutionally interesting use cases for VARA Category 1 ARVA tokens. The asset class — copyright royalties from music catalogues, residual income from film and TV libraries, patent licensing royalties from pharma and deep-tech portfolios — is large, fragmented, and increasingly held by sophisticated investors looking for predictable yield. The challenge has always been the operational friction of fractional ownership and the absence of a regulated secondary market.

The Hipgnosis Songs Fund showed there was institutional appetite for music-royalty securitisation. Royalty Exchange and Royalty Pharma proved similar appetite at the patent and life-sciences end. What has been missing is a regulated digital-asset framework that allows fractional ownership at smaller minimum sizes, on-chain transferability, and transparent royalty distribution. VARA Category 1 ARVA tokens are now that framework, sitting under the Virtual Asset Issuance Rulebook.

The three IP-tokenisation pathways.

1. Music catalogue royalties.

The catalogue owner assigns (or grants an exclusive licence over) the publishing and master rights to a Dubai SPV. The SPV is the legal owner of the rights and is the recipient of royalties from the relevant Performance Rights Organisations (ASCAP, BMI, SESAC, SOCAN, PRS, GEMA), the Mechanical Licensing Collective (MLC) in the US, and digital service providers (Spotify, Apple Music, YouTube). Token holders receive a defined share of the SPV's royalty receipts on a quarterly or monthly cycle.

2. Film and TV residual rights.

The producer or rights-holder assigns residual income rights from a film or television library to the SPV. Streaming income from Netflix, Amazon, Apple TV+, Disney+ and theatrical residual income flows to the SPV under the underlying licensing agreements. Token holders receive a share of the residual income stream. The Hollywood guild residuals (SAG-AFTRA, WGA, DGA) require careful contractual handling because they are not freely assignable in all cases.

3. Patent licensing royalties.

Patent holders (university tech transfer offices, pharma companies, deep-tech inventors) assign or licence patents to the SPV. The SPV then licences the patents to operators in return for licensing royalties (often calculated as a percentage of net sales of products embodying the patents). Token holders receive a share of the licensing royalties. Common in pharma (where patents have predictable 20-year cycles) and life sciences.

The legal architecture.

For all three pathways, the structure follows the same pattern:

  1. Originator (the existing rights-holder) assigns or exclusively licences the IP to the UAE Issuer SPV. The assignment is recorded in the relevant copyright/patent registers and recognised by the relevant PROs and licensees.
  2. UAE Issuer SPV is a Dubai entity (typically DMCC) holding a VARA Category 1 ARVA issuance licence. The SPV is the legal owner / licensee of the IP and the issuer of the tokens.
  3. Token holders hold ARVA tokens entitling them to a defined share of the SPV's royalty receipts after deducting administrative costs (paying agent fees, audit, tax).
  4. Paying agent handles royalty collection on behalf of the SPV — PRO collections, MLC collections, licensee-direct payments — and aggregates the cash flow.
  5. DLT registry records token ownership and processes pro-rata royalty distributions on the cycle (monthly or quarterly).

Royalty flow mechanics.

The royalty distribution cycle for a tokenised music catalogue typically runs:

  • Quarter end: PROs and MLC publish royalty statements for the quarter (usually with a 90-day lag).
  • Royalty receipt: SPV receives cash from PROs/MLC/DSPs in the quarter following the statement.
  • Reconciliation: Paying agent reconciles cash receipts to royalty statements; deducts administrative costs.
  • Distribution calculation: Net distributable income divided pro-rata across token holders of record on the distribution-date snapshot.
  • On-chain distribution: Cash distribution (typically in USD stablecoin or AED stablecoin) deployed to token holders via the DLT.

VARA Cat 1 requirements (rulebook overlay).

Under the VARA Virtual Asset Issuance Rulebook, IP-backed ARVA tokens must satisfy:

  • Reserve and asset backing disclosure: independent valuation of the underlying IP at issuance and on annual revaluation cycle.
  • Whitepaper: VARA-approved whitepaper disclosing the IP, the assignment chain, the royalty mechanics, the cash-flow waterfall, the risk factors.
  • Independent custodian arrangement: the underlying IP rights and the royalty bank accounts held in segregated structures.
  • Audit and reporting: quarterly investor reports and annual audit by a Big Four firm or equivalent.
  • Marketing perimeter: marketing only to qualified investors unless retail Cat 1 marketing approval obtained separately.

Worked example: USD 50 million music catalogue.

A US-based songwriter holds a catalogue of 500 songs generating USD 5 million per year in PRO + MLC + DSP royalties. The catalogue is valued at USD 50 million (10x annual royalties — broadly consistent with Hipgnosis-era pricing).

  1. Songwriter establishes a Dubai SPV (DMCC) for IP tokenisation purposes.
  2. Songwriter assigns the songwriter share of publishing and writer royalties to the SPV, recorded with US Copyright Office and registered with PROs (ASCAP/BMI), MLC and key DSPs.
  3. SPV applies for VARA Category 1 ARVA issuance licence. Whitepaper sets out catalogue composition, historical royalty performance, royalty waterfall, valuation methodology.
  4. SPV issues 50,000,000 ARVA tokens at USD 1.00 each, raising USD 50M from qualified investors.
  5. SPV deploys the USD 50M to the songwriter as the catalogue purchase price.
  6. SPV operates ongoing: receives royalties quarterly, distributes pro-rata net of admin costs to token holders.
  7. Token holders can transfer tokens on the VARA-licensed secondary market (subject to the marketing perimeter).

The UAE advantage.

For IP holders considering UAE-based tokenisation, the advantages over a Cayman or BVI structure are: (i) VARA Cat 1 is the only regulated framework that recognises ARVA structures under a comprehensive rulebook; (ii) the UAE Corporate Tax 0% rate for qualifying free zone persons can apply if structured correctly; (iii) the UAE has tax treaties with many royalty-source jurisdictions (US, UK, Germany, India, China) reducing withholding leakage; (iv) AED stablecoin infrastructure under the CBUAE PTSR provides cash-out optionality.

Conclusion.

IP tokenisation under VARA Cat 1 is one of the highest-value use cases for the regime — converting a previously private, fragmented asset class into a regulated, transferable digital asset. The structural mechanics are demanding but the rulebook fits the use case well. Neo Legal supports IP holders across the full SPV, VARA application, IP assignment, and ongoing administrative architecture.